Selected Recent Posters

2024 December - P4 PharmD student Madison Zelon presented Riese lab research findings at the ASHP Midyear meeting.  DOI.  Poster.

2024 November - Graduate student Dr. Vipasha Dwivedi presented Riese lab research findings at the Southeastern region Society of Toxicology meeting.  Poster.

2024 October - P2 PharmD student Chloé Dion and graduate student Dr. Vipasha Dwivedi presented an overview of research in the Riese laboratory at the Auburn University Faculty Showcase for Undergraduate Research.  Poster.  Picture of Chloé.

2024 June - National Cancer Institute Division of Cancer Biology R15 Investigator Workshop (Bethesda, MD) - "ERBB4 Heterodimers Appear to Drive BRAF WT Melanoma Cell Lines" - DOI.  Poster.

2024 April - AACR Annual Meeting (San Diego, CA) - "ERBB4 Heterodimers Appear to Drive BRAF WT Melanoma Cell Lines" - DOI.  Poster.

2022 December - American Association for Cancer Research and the Japanese Cancer Association joint meeting; "ERBB4 Drives BRAF-WT Melanoma"-  Poster.

2022 October - University of Alabama-Birmingham O'Neal Comprehensive Cancer Center Retreat; "ERBB4 is a Driver of BRAF-WT Melanoma" - Poster.

2022 April - Auburn University BMES Showcase - "ERBB4 is a Driver of BRAF-WT Melanoma" - Poster.

2022 April - AACR Annual Meeting (New Orleans, LA) - "ERBB4 is a Driver of BRAF-WT Melanoma" - Poster.

2021 July - AACR Annual Meeting (virtual) - "Identification of ERBB4 mutant alleles that function as tumor drivers" - Abstract.  Poster.

2020 October - EORTC-NCI-AACR Meeting (virtual) - "Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutant alleles as biomarkers and targets for novel combinatorial treatment strategies" - Poster.  Audio narration.

2020 October - AAPS Annual Meeting (virtual) - "Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutant alleles as biomarkers and targets for novel combinatorial treatment strategies" - Poster.  Audio narration.

2020 June - AACR Annual Meeting (virtual); "Targeting BRAF WT metastatic melanomas: Identifying ERBB4 mutant alleles as biomarkers and targets for novel combinatorial treatment strategies" - Poster.  Audio narration.